# AOH1996 for the Treatment of Refractory Solid Tumors

> **NCT05227326** · PHASE1 · RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 92 (estimated)

## Conditions studied

- Refractory Malignant Solid Neoplasm
- Osteosarcoma
- Leiomyosarcomas
- Synovial Sarcomas
- Ovarian Cancer
- Non-Small Cell Lung Cancer
- Pancreatic Cancer

## Interventions

- **DRUG:** PCNA Inhibitor AOH1996

## Key facts

- **NCT ID:** NCT05227326
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-12
- **Primary completion:** 2029-09-13
- **Final completion:** 2029-09-13
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05227326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05227326, "AOH1996 for the Treatment of Refractory Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05227326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*